0000899243-20-010885.txt : 20200417
0000899243-20-010885.hdr.sgml : 20200417
20200417080105
ACCESSION NUMBER: 0000899243-20-010885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200415
FILED AS OF DATE: 20200417
DATE AS OF CHANGE: 20200417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duke William E.
CENTRAL INDEX KEY: 0001636135
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38822
FILM NUMBER: 20797766
MAIL ADDRESS:
STREET 1: C/O VALERITAS, INC., 750 ROUTE 202 SOUTH
STREET 2: SUITE 600
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kaleido Biosciences, Inc.
CENTRAL INDEX KEY: 0001751299
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 617-674-9000
MAIL ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-15
0
0001751299
Kaleido Biosciences, Inc.
KLDO
0001636135
Duke William E.
C/O KALEIDO BIOSCIENCES, INC.
65 HAYDEN AVE.
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
6.00
2020-04-15
4
A
0
50000
0.00
A
2030-04-14
Common Stock
50000
50000
D
25% of this option shall vest on April 15, 2021, with the remaining 75% vesting in 12 equal quarterly installments thereafter.
/s/ Jerald Korn, as Attorney-in-Fact
2020-04-17